Physician profile
Mitchell Lee Hunter
NPI 1558861245
$7,257.72
in general payments reported to CMS, 2019-2025
10 companies · $3,038 in 2025
The $3,038 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,076 · 2021: $562 · 2022: $1,200 · 2023: $454 · 2024: $929 · 2025: $3,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,224 · Food and Beverage: $2,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,224.02 |
| Food and Beverage | $2,196.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,802.60 | 2024-2025 | Persona, G7 |
| Exactech, INC. | $1,254.87 | 2021-2024 | |
| Southern Edge Orthopaedics, INC. | $1,242.05 | 2019-2023 | |
| Reel Surgical, INC. | $1,200.00 | 2022 | |
| Arthrex, INC. | $337.91 | 2025 | |
| Bone Support INC. | $152.19 | 2024 | Cerament G, Ceramentbone Void Filler |
| Stryker Corporation | $101.78 | 2023-2024 | Blueprint Patient Specific Instrumentation, Axsos |
| Depuy Synthes Sales INC. | $100.74 | 2024 | Na |
| Smith+Nephew, INC. | $44.58 | 2023 | Anthology, Or3o Dual Mobility, Trigen Intertan |
| Titan Surgical Group, LLC | $21.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.